DHP-1401

N/A

Report date: 2024/08/01 20:00:04
NME

Base Information

Drug NameDHP-1401
Drug Alias NameDHP-1401
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate receptor ionotropic AMPA modulatorsMitogen-activated protein kinase modulators
TargetsMitogen-activated protein kinaseGlutamate receptor ionotropic AMPA
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesDae Hwa Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDae Hwa Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A